CD248 and non-small cell lung carcinoma: NSCLC patients with higher CD248 levels had shorter survival times than patients with lower CD248 levels according to the Gene Expression Profiling Interactive Analysis (GEPIA) database (http://gepia.cancer‐pku.cn/) (Figure 1B).